Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy

被引：31
作者：
Zhu, Huang [1 ]
Lai, Yi-Shin [1 ]
Li, Ye [1 ]
Blum, Robert H. [1 ]
Kaufman, Dan S. [1 ]
机构：
[1] Univ Calif San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92103 USA
来源：
STEM CELLS | 2018年 / 36卷 / 02期
关键词：
Cancer immunotherapy; Adoptive cell therapy; Human pluripotent stem cell; T cell; Natural Killer cell; Natural Killer T cell; NATURAL-KILLER-CELLS; CHIMERIC ANTIGEN RECEPTORS; UMBILICAL-CORD BLOOD; TUMOR-INFILTRATING LYMPHOCYTES; ACUTE MYELOID-LEUKEMIA; T-CELLS; HEMATOPOIETIC STEM; NK CELLS; IN-VIVO; ADOPTIVE TRANSFER;
D O I：
10.1002/stem.2754
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Human pluripotent stem cells (PSCs) provide a promising resource to produce immune cells for adoptive cellular immunotherapy to better treat and potentially cure otherwise lethal cancers. Cytotoxic T cells and natural killer (NK) cells can now be routinely produced from human PSCs. These PSC-derived lymphocytes have phenotype and function similar to primary lymphocytes isolated from peripheral blood. PSC-derived T and NK cells have advantages compared with primary immune cells, as they can be precisely engineered to introduce improved anti-tumor activity and produced in essentially unlimited numbers.
引用
收藏
页码：134 / 145
页数：12
相关论文
共 50 条
  • [31] Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells
    Ferreira-Teixeira, Margarida
    Paiva-Oliveira, Daniela
    Parada, Belmiro
    Alves, Vera
    Sousa, Vitor
    Chijioke, Obinna
    Munz, Christian
    Reis, Flavio
    Rodrigues-Santos, Paulo
    Gomes, Celia
    BMC MEDICINE, 2016, 14
  • [32] NK cell-based immunotherapy for malignant diseases
    Cheng, Min
    Chen, Yongyan
    Xiao, Weihua
    Sun, Rui
    Tian, Zhigang
    CELLULAR & MOLECULAR IMMUNOLOGY, 2013, 10 (03) : 230 - 252
  • [33] NK cell-based cancer immunotherapy: from basic biology to clinical application
    Li Yang
    Yin Jie
    Li Ting
    Huang Shan
    Yan Han
    Leavenworth JianMei
    Wang Xi
    SCIENCE CHINA-LIFE SCIENCES, 2015, 58 (12) : 1233 - 1245
  • [34] Natural killer cell-based immunotherapy in cancer: current insights and future prospects
    Sutlu, T.
    Alici, E.
    JOURNAL OF INTERNAL MEDICINE, 2009, 266 (02) : 154 - 181
  • [35] Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies
    Heslop, James A.
    Hammond, Thomas G.
    Santeramo, Ilaria
    Piella, Agnes Tort
    Hopp, Isabel
    Zhou, Jing
    Baty, Roua
    Graziano, Enrique I.
    Marco, Bernabe Proto
    Caron, Alexis
    Skold, Patrik
    Andrews, Peter W.
    Baxter, Melissa A.
    Hay, David C.
    Hamdam, Junnat
    Sharpe, Michaela E.
    Patel, Sara
    Jones, David R.
    Reinhardt, Jens
    Danen, Erik H. J.
    Ben-David, Uri
    Stacey, Glyn
    Bjorquist, Petter
    Piner, Jacqueline
    Mills, John
    Rowe, Cliff
    Pellegrini, Giovanni
    Sethu, Swaminathan
    Antoine, Daniel J.
    Cross, Michael J.
    Murray, Patricia
    Williams, Dominic P.
    Kitteringham, Neil R.
    Goldring, Chris E. P.
    Park, B. Kevin
    STEM CELLS TRANSLATIONAL MEDICINE, 2015, 4 (04) : 389 - 400
  • [36] Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
    Uppendahl, Locke D.
    Dahl, Carly M.
    Miller, Jeffrey S.
    Felices, Martin
    Geller, Melissa A.
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [37] Concise Review: Stem Cell-Based Approaches to Red Blood Cell Production for Transfusion
    Shah, Siddharth
    Huang, Xiaosong
    Cheng, Linzhao
    STEM CELLS TRANSLATIONAL MEDICINE, 2014, 3 (03) : 346 - 355
  • [38] Immunosenescence: limitations of natural killer cell-based cancer immunotherapy
    Tarazona, Raquel
    Sanchez-Correa, Beatriz
    Casas-Aviles, Ignacio
    Campos, Carmen
    Pera, Alejandra
    Morgado, Sara
    Lopez-Sejas, Nelson
    Hassouneh, Fakhri
    Bergua, Juan M.
    Jose Arcos, Maria
    Banas, Helena
    Casado, Javier G.
    Duran, Esther
    Labella, Fernando
    Solana, Rafael
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (02) : 233 - 245
  • [39] Dendritic cell-based cancer immunotherapy for pancreatic cancer
    Li, Wei
    Song, Xiujun
    Yu, Huijie
    Zhang, Manze
    Li, Fengsheng
    Cao, Cheng
    Jiang, Qisheng
    ARAB JOURNAL OF GASTROENTEROLOGY, 2018, 19 (01) : 1 - 6
  • [40] Natural Killer Cell-Based Immunotherapy for Cancer: Advances and Prospects
    Hu, Yuan
    Tian, Zhigang
    Zhang, Cai
    ENGINEERING, 2019, 5 (01) : 106 - 114
12345